Evidence map›Paper›PMID 28930961›Full record

ArticleThe journal of trauma and acute care surgery2017

Impact of a novel phosphoinositol-3 kinase inhibitor in preventing mitochondrial DNA damage and damage-associated molecular pattern accumulation: Results from the Biochronicity Project.

George Edward Black, Kyle K Sokol, Donald M Moe, Jon D Simmons, David Muscat, Victor Pastukh, Gina Capley, Olena Gorodnya, Mykhaylo Ruchko, Mark B Roth and 2 more

Abstract read
In one paragraph

Article in The journal of trauma and acute care surgery, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

George Edward BlackFrom the Department of Surgery (G.E.B., K.K.S., D.M.M., M.J.M.), Madigan Army Medical Center, Joint Base Lewis-McChord, Washington; Department of Surgery (J.S.), University of South Alabama, Mobile, Alabama; Department of Pharmacology (D.M., V.P., G.C., O.G., M.R., M.G.), University of South Alabama, Mobile, Alabama; Basic Sciences Division (M.B.R.), Fred Hutchinson Cancer Research Center, Seattle, Washington; and Trauma and Acute Care Surgery Service (M.J.M.), Legacy Emanuel Medical Center, Portland, Oregon.
Kyle K Sokol
Donald M Moe
Jon D Simmons
David Muscat
Victor Pastukh
Gina Capley
Olena Gorodnya
Mykhaylo Ruchko
Mark B Roth
Mark Gillespie
Matthew J Martin
University of South Alabama · US

Funding

MtDNA repair: An isolated pharmacologic target in acute lung injuryR01HL113614 · NHLBI · UNIVERSITY OF SOUTH ALABAMA · PI GILLESPIE, MARK N · 2012 to 2021
$3.5M
mtDNA DAMPS: a pharmacologic target in multi-organ system failureK08GM109113 · NIGMS · UNIVERSITY OF SOUTH ALABAMA · PI SIMMONS, JON DAVID · 2016 to 2019
$756k
NHLBI NIH HHS R01 HL113614NIGMS NIH HHS K08 GM109113
6 · The paper itself

Abstract

backgroundDespite improvements in the management of severely injured patients, development of multiple organ dysfunction syndrome (MODS) remains a morbid complication of traumatic shock. One of the key attributes of MODS is a profound bioenergetics crisis, for which the mediators and mechanisms are poorly understood. We hypothesized that metabolic uncoupling using an experimental phosphoinositol-3 kinase (PI3-K) inhibitor, LY294002 (LY), may prevent mitochondrial abnormalities that lead to the generation of mitochondrial DNA (mtDNA) damage and the release of mtDNA damage-associated molecular patterns (DAMPs).

methodsSixteen swine were studied using LY, a nonselective PI3-K inhibitor. Animals were assigned to trauma only (TO, n = 3), LY drug only (LYO, n = 3), and experimental (n = 10), trauma + drug (LY + T) groups. Both trauma groups underwent laparotomy, 35% hemorrhage, severe ischemia-reperfusion injury, and protocolized resuscitation. A battery of hemodynamic, laboratory, histological, and bioenergetics parameters were monitored. Mitochondrial DNA damage was determined in lung, liver, and kidney using Southern blot analyses, whereas plasma mtDNA DAMP analysis used polymerase chain reaction amplification of a 200-bp sequence of the mtDNA D-loop region.

resultsRelative to control animals, H + I/R (hemorrhage and ischemia/reperfusion) produced severe, time-dependent decrements in hepatic, renal, cardiovascular, and pulmonary function accompanied by severe acidosis and lactate accumulation indicative of bioenergetics insufficiency. The H-I/R animals displayed prominent oxidative mtDNA damage in all organs studied, with the most prominent damage in the liver. Mitochondrial DNA damage was accompanied by accumulation of mtDNA DAMPs in plasma. Pretreatment of H + I/R animals with LY resulted in profound metabolic suppression, with approximately 50% decreases in O2 consumption and CO2 production. In addition, it prevented organ and bioenergetics dysfunction and was associated with a significant decrease in plasma mtDNA DAMPs to the levels of control animals.

conclusionsThese findings show that H + I/R injury in anesthetized swine is accompanied by MODS and by significant mitochondrial bioenergetics dysfunction, including oxidative mtDNA damage and accumulation in plasma of mtDNA DAMPs. Suppression of these changes with the PI3-K inhibitor LY indicates that pharmacologically induced metabolic uncoupling may comprise a new pharmacologic strategy to prevent mtDNA damage and DAMP release and prevent or treat trauma-related MODS. LEVEL OF EVIDENCE: Therapeutic study, level III.

Indexed as

DNA DamageDNA, MitochondrialAnimalsChromonesDisease Models, AnimalEnergy MetabolismEnzyme InhibitorsMorpholinesMultiple Organ FailureShock, TraumaticSwine2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-oneChromonesDNA, MitochondrialEnzyme InhibitorsMorpholines

Identifiers

PMID28930961
PMCPMC5938741
OpenAlexW2617971595

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.